Related Experiment Video

Updated: Jun 4, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Major clinical research advances in gynecologic cancer in 2010

Dong Hoon Suh1, Jae Weon Kim, Kidong Kim

  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

Journal of Gynecologic Oncology
|February 1, 2011
PubMed

Insights

This review highlights 2010 gynecologic oncology advances, including ovarian cancer treatments like bevacizumab, cervical cancer screening with HPV tests, and endometrial cancer surgical staging. It also covers geriatric oncology and carcinosarcoma chemotherapy.

Area of Science:

  • Gynecologic Oncology
  • Clinical Research

Background:

  • Significant clinical research advancements occurred in gynecologic oncology during 2010.
  • Key areas reviewed include ovarian, cervical, and endometrial cancers, alongside geriatric oncology and carcinosarcomas.

Purpose of the Study:

  • To summarize major clinical research advances in gynecologic oncology from 2010.
  • To provide an overview of novel treatments, diagnostic methods, and trends in the field.

Main Methods:

  • Review of 11 major clinical research advances.
  • Synthesis of findings related to specific gynecologic cancers and broader trends.

Main Results:

  • Ovarian cancer: Bevacizumab, pegylated liposomal doxorubicin, neoadjuvant chemotherapy, screening, and ARID1A mutations.
  • Cervical cancer: Human papillomavirus (HPV) testing efficacy, self-collection, and HPV vaccine safety (miscarriage association).
  • Endometrial cancer: Laparoscopy superiority, vaginal brachytherapy, and para-aortic lymph node dissection.

Conclusions:

  • The year 2010 saw substantial progress in molecular targeted agents, diagnostic techniques, and surgical approaches for gynecologic cancers.
  • Emerging trends in geriatric oncology and specific chemotherapy regimens for carcinosarcomas were also assessed.
Keywords:
BevacizumabGeriatric oncologyOvarian cancer screening

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...